When we determined levels of various individual amino acids, we observed no differences between normal KLS+ and CML-KLS+ cells (Fig. 1b; Supplementary Data 1). This evidence concerns the gene RPS6KB2 and chronic myelogenous leukemia, BCR-ABL1 positive.